WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001005353) USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/005353    International Application No.:    PCT/DK2000/000401
Publication Date: 25.01.2001 International Filing Date: 14.07.2000
Chapter 2 Demand Filed:    09.02.2001    
IPC:
A61K 38/00 (2006.01), C12N 9/64 (2006.01)
Applicants: NOVO NORDISK A/S [DK/DK]; Novo Allé, DK-2880 Bagsvaerd (DK) (For All Designated States Except US).
EZBAN, Mirella [DK/DK]; (DK) (For US Only).
PETERSEN, Lars, Christian [DK/DK]; (DK) (For US Only).
SIEGBAHN, Agneta [SE/SE]; (SE) (For US Only)
Inventors: EZBAN, Mirella; (DK).
PETERSEN, Lars, Christian; (DK).
SIEGBAHN, Agneta; (SE)
Common
Representative:
NOVO NORDISK A/S; Novo Allé, DK-2880 Bagsvaerd (DK)
Priority Data:
PA 1999 01023 14.07.1999 DK
60/148,300 11.08.1999 US
PA 1999 01117 12.08.1999 DK
Title (EN) USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS
(FR) UTILISATION DE FVIIa OU D'UN ANTAGONISTE DE FACTEUR TISSULAIRE TF POUR REGULER L'EXPRESSION GENIQUE, ET MIGRATION CELLULAIRE OU CHIMIOTAXIE
Abstract: front page image
(EN)The present invention relates to use of FVII and/or FVIIa and/or another TF agonist and/or FVIIai and/or another TF antagonist in therapeutic treatment of pathological conditions that can be related to cell migration or treated by specific regulation of cell migration or chemotaxis. The invention also relates to the use of FVII and/or FVIIa and/or another TF agonist and/or FVIIai and/or another TF antagonist in therapeutic treatment of pathological conditions that can be related to regulation of expression of at least one gene in a cell, e.g., Cyr61gene.
(FR)L'invention concerne l'utilisation d'un agoniste TF et/ou FVII et/ou FVIIa, et/ou d'un antagoniste TF et/ou FVIIai, dans le traitement thérapeutique d'états pathologiques pouvant être associés à la migration cellulaire, ou traités par régulation spécifique de la migration cellulaire ou chimiotaxie. L'invention concerne également l'utilisation d'un agoniste TF et/ou FVII et/ou FVIIa, et/ou d'un antagoniste TF et/ou FVIIai dans le traitement d'états pathologiques pouvant être associés à la régulation de l'expression d'au moins un gène dans une cellule, par exemple le gène Cyr61.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)